Literature DB >> 14838590

Studies on haemagglutination by the EMC-MM-Columbia SK-group of viruses. III. Destruction of virus receptors in vitro and in vivo.

J D VERLINDE, P de BAAN, A KRET, P WALLER-FETTER.   

Abstract

Entities:  

Keywords:  AGGLUTINATION; VIRUSES

Mesh:

Substances:

Year:  1951        PMID: 14838590     DOI: 10.1007/bf02062258

Source DB:  PubMed          Journal:  Antonie Van Leeuwenhoek        ISSN: 0003-6072            Impact factor:   2.271


× No keyword cloud information.
  7 in total

1.  Modification of human red cells by virus action; the receptor gradient for virus action in human red cells.

Authors:  F M BURNET; J F McCREA; J D STONE
Journal:  Br J Exp Pathol       Date:  1946-08

2.  The initiation of cellular infection by influenza and related viruses.

Authors:  F M BURNET
Journal:  Lancet       Date:  1948-01-03       Impact factor: 79.321

3.  Prevention of virus infection with enzyme of V. cholerae; studies with viruses of mumps-influenza group in chick embryos.

Authors:  J D STONE
Journal:  Aust J Exp Biol Med Sci       Date:  1948-01

4.  Hemagglutination by Columbia SK, Columbia MM, mengo encephalomyelitis and encephalomyocarditis viruses; experiments with other viruses.

Authors:  P K OLITSKY; R H YAGER
Journal:  Proc Soc Exp Biol Med       Date:  1949-08

5.  [Agglutination of erythrocytes by murine strains of poliomyelitic virus].

Authors:  A BREMER
Journal:  Ann Inst Pasteur (Paris)       Date:  1951-01

6.  Nonspecific serum inhibition of influenza haemagglutination.

Authors:  J F McCREA
Journal:  Aust J Exp Biol Med Sci       Date:  1946-12

7.  Further experiments with Columbia SK murine poliomyelitis virus.

Authors:  C W JUNGEBLUT
Journal:  Bull N Y Acad Med       Date:  1950-08
  7 in total
  1 in total

1.  Studies on haemagglutination by the EMC-MM-Columbia SK-group of viruses. IV. Experiments with egg-adapted virus.

Authors:  J D VERLINDE; P WALLER-FETTER; P de BAAN
Journal:  Antonie Van Leeuwenhoek       Date:  1951       Impact factor: 2.271

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.